… In animal models of Parkinson’s disease (PD), BDNF enhances the survival … therapies of
PD are symptom-targeting, and their effectiveness decreases with the progression of the disease…

… appear to have most therapeutic promise based on concepts, feasibility in a reasonable time
frame, and available clinical data and place an emphasis on disease-modifying treatments. …

… neurons may be a promising therapy for Parkinson’s disease. There are … in the animal
model of Parkinson’s disease proves that it is … the symptoms of Parkinson’s disease but also on …

… bilirubin as a potential disease-modifying therapy for PD. … therapy for PD, owing to the
plethora of the multiple mechanisms involved in the disease, bilirubin is a promising single-therapy …

Parkinson's disease (PD) is a progressive movement disorder resulting primarily from loss
of nigrostriatal dopaminergic neurons. PD is characterized by the accumulation of protein …

… should be tested to determine whether they are a promising therapeutic option for PD. …
and their effector mechanisms might represent promising therapeutic strategies for PD. …

… Therefore, and in view of the importance of bacterial composition in this disease, faecal
microbiota transplants (FMT) are proving to be a promising therapeutic approach in the …

… for Parkinson’s disease. This is of particular interest because ROCK inhibitors are currently
used against vascular diseases … use on the risk of Parkinson disease. Neurology 65:383–90. …

… as a new therapeutic target has been recommended as a promising therapy for PD. The …
Despite promising preclinical studies for PD, use of cannabinoids has not been studied …

… of PD, suggesting that inhibition of inflammation might become a promising therapeutic
intervention for PD. Parkinson's disease (PD) is one of the major neurodegenerative disorders …